Stocks and Investing
Stocks and Investing
Fri, March 20, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, March 19, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Aydin Huseynov Initiated (VYGR) at Strong Buy and Held Target at $18 on, Mar 19th, 2020
Aydin Huseynov of Benchmark, Initiated "Voyager Therapeutics, Inc." (VYGR) at Strong Buy and Held Target at $18 on, Mar 19th, 2020.
Aydin has made no other calls on VYGR in the last 4 months.
There are 3 other peers that have a rating on VYGR. Out of the 3 peers that are also analyzing VYGR, 1 agrees with Aydin's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Jeffrey Hung of "Morgan Stanley" Maintained at Hold with Decreased Target to $14 on, Wednesday, March 4th, 2020
These are the ratings of the 2 analyists that currently disagree with Aydin
- Laura Chico of "Wedbush" Maintained at Buy with Decreased Target to $27 on, Wednesday, March 4th, 2020
- Jay Olson of "Oppenheimer" Initiated at Buy and Held Target at $26 on, Thursday, February 6th, 2020